Updated Oct 28, 2026 · 12:56 UTC
VRTXVertex Pharmaceuticals Incorporated
Health Care · United States · XNAS · pharmaceutical preparations
$521.00+0.68%last session · market early-hours
Market cap
$132.05b
real-world
Tokenized
$7k
<0.001% of the asset
Avg token price
$512.46
−1.64% vs real
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
VRTX · Price
Token Real
EarningsNasdaq’s earnings calendar
Next earnings
Nov 2
after the close · Sep 2026 quarter · EPS forecast $4.36 (5 analysts)
Last earnings, Aug 3
$4.20 EPS
+1.2% vs $4.15 forecast · Jun 2026 quarter
Real marketVertex Pharmaceuticals Inc
Last close
$521.03
Oct 27
Traded on Oct 27
$528.7m
Price now
$521.00
market early-hours
Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
In DeFiPools and lending markets that hold these tokens
None found
Onchain versions2 tokens from 2 issuers
VRTXonOndo Assetstied here$512.46$7k
wVRTXxBacked Assets——HoldersAddresses holding its tokens on each chain counted, each token counted and added, issuers’ own addresses left out · the value is what they hold onchain
BNB Chain37 holders$6k
Ethereum17 holders$2k
Solana6 holders$112Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$12.59b
+10% YoY
Operating income
$4.78b
38% margin · +22% YoY
Net income
$4.41b
35% margin · +21% YoY
EPS, diluted
$17.26
+23% YoY
Diluted shares
255m
−1% YoY
Cash and balance sheet
Free cash flow
$3.80b
30% of revenue · 2.9% yield
Cash and securities
$13.64b
debt not tagged
Quarterly
RevenueNet income
Valuation today’s market cap $132.05b
P/E
30.0×
P/S
10.5×